Telesis Bio, Inc.
MESSENGER RNA VACCINES AND USES THEREOF

Last updated:

Abstract:

The present invention provides, among other things, methods and compositions of formulating nucleic acid-containing nanoparticles for efficient delivery of payload in vivo such that the method and compositions can be used to generate mRNA vaccines.

Status:
Application
Type:

Utility

Filling date:

29 May 2019

Issue date:

16 Jan 2020